Topiramate
Who holds supplier records for Topiramate? 19 organisations hold a current record for Topiramate: an active US FDA Type II Drug Master File or a CEP. A further 9 organisations have only historical (inactive) DMF filings. 4 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (14), Belgium (1), Taiwan (1), Poland (1) and 1 other country (1); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Topiramate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/topiramate
Reading the evidence
- 19 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
14 of the 18 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 14 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Topiramate expires 21 Aug 2040. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (19)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Topiramate. Country is the organisation's recorded country, not necessarily the manufacturing site.
- UNIMARK REMEDIES LTDIndiaActive DMF 23349, 20932 · latest filing Nov 2009
- APITORIA PHARMA PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 19247 · latest filing Mar 2006
- Hetero Drugs LimitedIndiaCEP Company GMP cert on recordActive DMF 18346 · latest filing May 2005
- MSN Organics Private LimitedIndiaCEPActive DMF 25713 · latest filing Jan 2012
- Zydus Lifesciences LimitedIndiaCEP Company GMP cert on recordActive DMF 18700 · latest filing Aug 2005
- ALIVUS LIFE SCIENCES LTDIndia Company GMP cert on recordActive DMF 17729 · latest filing Oct 2004
- Cipla LimitedIndia Company GMP cert on recordActive DMF 15693 · latest filing Oct 2001
- Dr. Reddy's Laboratories Ltd.India Company GMP cert on recordActive DMF 16533 · latest filing Mar 2003
- GLOBAL CALCIUM PRIVATE LTDIndia Company GMP cert on recordActive DMF 39636 · latest filing Mar 2024
- HUADONG MEDICINE (XI'AN) BODYGUARD PHARMACEUTICAL CO LTDActive DMF 40829 · latest filing Dec 2024
- Janssen Pharmaceutica NVBelgium Company GMP cert on recordActive DMF 10919 · latest filing May 1994
- Nifty Labs Pvt LtdIndia Company GMP cert on recordActive DMF 44222 · latest filing Jul 2026
- SCINOPHARM TAIWAN LTDTaiwanActive DMF 17035 · latest filing Dec 2003
- SNJ LIFECARE PVT LTDIndiaActive DMF 42032 · latest filing Jun 2025
- Sun Pharmaceutical Industries LimitedIndia Company GMP cert on recordActive DMF 18172 · latest filing Mar 2005
- Torrent PharmaceuticalsIndia Company GMP cert on recordActive DMF 20386 · latest filing Mar 2007
- Unichem Laboratories Ltd.India Company GMP cert on recordActive DMF 35191 · latest filing Sept 2020
- Zakłady Farmaceutyczne Polpharma S.A.Poland Company GMP cert on recordActive DMF 20581 · latest filing Jun 2007
- Zhejiang Huahai Pharmaceutical Co., Ltd.China Company GMP cert on recordActive DMF 28371 · latest filing Jun 2014
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (4)
Certificates of Suitability on the EDQM register for Topiramate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| HETERO DRUGS LIMITED Hyderabad | IN | CEP 2020-130 - Rev 02 Topiramate | Feb 2026 | — |
| ZYDUS LIFESCIENCES LIMITED Vadodara | IN | CEP 2021-419 - Rev 02 Topiramate | Sept 2025 | — |
| APITORIA PHARMA PRIVATE LIMITED Hyderabad | IN | CEP 2020-140 - Rev 04 Topiramate | Mar 2025 | — |
| MSN ORGANICS PRIVATE LIMITED Bibinagar Village | IN | R0-CEP 2020-201 - Rev 01 Topiramate | Mar 2022 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (9)
Organisations whose Type II DMFs for Topiramate are no longer active. These show a past filing, not current supply.
Show all 9 historical records
- India · Inactive DMF 24833, 27439 · filed Sept 2013
- DISHMAN PHARMACEUTICALS AND CHEMICALS LTDInactive DMF 26919, 22745 · filed Feb 2013
- SIGNA SA DE CVInactive DMF 21657 · filed May 2008
- India · Inactive DMF 21068 · filed Nov 2007
- India · Inactive DMF 19325 · filed Mar 2006
- CF PHARMA LTDInactive DMF 18269 · filed Apr 2005
- Hungary · Inactive DMF 16405 · filed Jan 2003
- FERRO PFANSTIEHL LABORATORIES INCInactive DMF 15658 · filed Oct 2001
- Switzerland · Inactive DMF 10978 · filed Jul 1994
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (137 listed products contain Topiramate). The latest listed patent expires 21 Aug 2040. The latest listed exclusivity ended 1 Feb 2026. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Topiramate is a medication used primarily to treat epilepsy and prevent migraines. It is known for its broad-spectrum anticonvulsant properties and is generally well-tolerated in diverse patient populations.
Chemical identity
- IUPAC name
- [(1R,2S,6S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecan-6-yl]methyl sulfamate
- Canonical SMILES
- CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C
- InChIKey
- KJADKKWYZYXHBB-XBWDGYHZSA-N
- Synonyms
- Topamax API, (-)-topiramate, epitoma, epitomax, eprontia, mcn-4853, qsymia component topiramate, qudexy, rwj-17021, rwj-17021-000, sincronil, topamac
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Mechanism of action
- Cytochrome P450 2C19 Inhibitors; Cytochrome P450 3A4 Inducers
- Physiologic effect
- Decreased Central Nervous System Disorganized Electrical Activity
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Topiramate?
19 organisations hold an active US FDA Type II Drug Master File or a CEP for Topiramate: UNIMARK REMEDIES LTD (India), APITORIA PHARMA PRIVATE LTD (India), Hetero Drugs Limited (India), MSN Organics Private Limited (India), Zydus Lifesciences Limited (India), ALIVUS LIFE SCIENCES LTD (India), Cipla Limited (India) and Dr. Reddy's Laboratories Ltd. (India), and 11 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Topiramate Drug Master Files are active?
UNIMARK REMEDIES LTD (DMF 23349, 20932), APITORIA PHARMA PRIVATE LTD (DMF 19247), Hetero Drugs Limited (DMF 18346), MSN Organics Private Limited (DMF 25713), Zydus Lifesciences Limited (DMF 18700), ALIVUS LIFE SCIENCES LTD (DMF 17729), Cipla Limited (DMF 15693) and Dr. Reddy's Laboratories Ltd. (DMF 16533) and 11 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Topiramate records mean?
9 organisations have only inactive Type II DMFs for Topiramate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Topiramate have a European Certificate of Suitability?
Yes. 4 organisations hold a valid CEP for Topiramate on the EDQM register, including HETERO DRUGS LIMITED Hyderabad (IN), ZYDUS LIFESCIENCES LIMITED Vadodara (IN), APITORIA PHARMA PRIVATE LIMITED Hyderabad (IN) and MSN ORGANICS PRIVATE LIMITED Bibinagar Village (IN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
Does the FDA Orange Book list patents for products containing Topiramate?
Yes. The latest patent listed for an approved US product containing Topiramate expires 21 Aug 2040, across 137 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Topiramate supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Topiramate?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.